P53 INVEST AS • 921517378 • Stavanger • Real estate activities

This website uses cookies to enhance the user experience.

Goods and trade

P53 INVEST AS

Keywords

apartmentsrentalagricultural landagricultural properties

Organization

CEO: SS
Susanne Stuffers1981
Chairman of the board: KS
Kjell Skappel1977
Years since formation: 7 years; since Oct 5, 2018
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 273,330; 1 share class
Total number of shareholders: 2; companies
Belongs to group of

Financials

Annual total result 2023: 13,232,882; NOK
Total equity 2023: 86,328,318; NOK

Last update: Sep 12, 2024

Management

Management / administration

Name	Role	Shares
SS Susanne Stuffers 1981	Managing Director/CEO	20 % indirectly

Board

Name	Role	Shares
KS Kjell Skappel 1977	Chairman	-
SS Susanne Stuffers 1981	Board Member	20 % indirectly
SV Silje Veen 1971	Board Member	14.29 % indirectly
ØS Øyvind Gjærevoll Schanke 1968	Board Member	-

Others

Name	Role	Shares
E ERGA REVISJON AS	Auditor	-
D DYNAMIK SMART ACCOUNTING AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
SS Susanne Stuffers 1981	Managing Director/CEO, Board Member	20 % indirectly
TD Tor Dagfinn Veen 1947	-	19.56 % indirectly
SV Silje Veen 1971	Board Member	14.29 % indirectly
LR Leo Veen Røe 2004	-	10.29 % indirectly
CV Camilla Veen 1975	-	8 % indirectly
JU Julian Veen Uldal 1997	-	7.14 % indirectly
LU Lars Veen Uldal 1999	-	7.14 % indirectly
TV Tone Veen 1946	-	3.3 % indirectly

Last update: Apr 13, 2023

Ownership

Company shareholders

Name	Share class	Number of shares	Share
T T.D. VEEN AS	Ordinary shares	218,664	80 %
U UBIQUITY AS	Ordinary shares	54,666	20 %

Shares owned by the P53 INVEST AS

Name	Share class	Number of shares	Share
P PACERTOOL AS	Ordinary shares	23,026	20.5 %
C CALLUNA PHARMA POOLCO AS	Preference shares	5,661,407	16.18 %
D DEONTIKK INVESTERING AS	NO0010720675	2,660,000	6.27 %
E EXACT THERAPEUTICS AS	NO0010852213	726,500	2.26 %
G GENTIAN DIAGNOSTICS ASA	NO0010748866	133,255	0.86 %
N NYKODE THERAPEUTICS ASA	NO0010714785	950,762	0.29 %
S SALAMANDER INVEST AS	NO0010754773	361,010	0.06 %

Last update: May 24, 2024

Group structure

T.D. VEEN AS
Total operating income 2023: NOK 248,278,000
Operating profit 2023: NOK 194,661,000
Employees: 8

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	0	0	0
Annual Total Result	13,232,882	-15,055,128	14,407,960
Total assets	170,101,645	97,487,640	110,721,844
Total liabilities	83,773,326	24,392,204	22,571,279
Total equity	86,328,318	73,095,437	88,150,565

P&L

Year	2023	2022	2021
Total operating income	0	0	0
Total operating costs	4,251,441	2,844,083	1,723,937
Operating result	-4,251,441	-2,844,083	-1,723,937
Financial income/costs	17,484,322	-12,211,045	16,131,897
Profit before tax	13,232,882	-15,055,128	14,407,960
Total tax & extraordinary income/cost	0	0	0
Annual Total Result	13,232,882	-15,055,128	14,407,960

Balance overview

Year	2023	2022	2021
Total fixed assets	116,166,168	36,832,432	24,163,197
Total current assets	53,935,476	60,655,209	86,558,647
Total assets	170,101,645	97,487,640	110,721,844
Short term debt	1,678,326	518,204	486,279
Long term debt	82,095,000	23,874,000	22,085,000
Total liabilities	83,773,326	24,392,204	22,571,279
Contributed capital	8,199,900	8,199,900	8,199,900
Retained earnings	78,128,418	64,895,537	79,950,665
Total equity	86,328,318	73,095,437	88,150,565
Total equity and liabilities	170,101,645	97,487,640	110,721,844

Classification

Category

Goods and trade

Type of organization

Limited company

Classification of institutional sector

INNL

Domestic sectors

A_IKKE-FIN

Non-financial corporations

2100

Private non-financial incorporated enterprises

Standard industrial classification

L

Main industrial area

Real estate activities

68

Activity

Real estate activities

68.2

Main industrial group

Renting and operating of own or leased real estate

68.20

Industrial group

Renting and operating of own real estate

68.209

Industrial group

Other letting of real estate